Keywords: مولتیپل میلوما; Monoclonal gammopathy; Multiple myeloma; Lymphoproliferative syndrome; Biological treatments; TNFα antagonists;
مقالات ISI مولتیپل میلوما (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مولتیپل میلوما; multiple myeloma; immunomodulatory drugs; proteasome inhibitors; treatment; side effects;
Keywords: مولتیپل میلوما; survivorship; transition points; multiple myeloma; caregivers; communication;
Keywords: مولتیپل میلوما; amyloidosis; angioendotheliomatosis; cryoglobulins; crystalglobulins; heavy chains; immunoglobulin; light chains; macroglobulinosis; paraprotein; AL; amyloid light chain; CG; cryoglobulinemia; CS; cryokeratotic spicules; CSH; crystal-storing histiocytosis
Keywords: مولتیپل میلوما; multiple myeloma; hematopoietic stem cell transplantation; caregivers; treatment; resources;
Keywords: مولتیپل میلوما; young adults; oncology; multiple myeloma; fertility;
Keywords: مولتیپل میلوما; side effects; symptom management; multiple myeloma;
Keywords: مولتیپل میلوما; multiple myeloma; health-related quality of life; patient-reported outcome; PRO; patient-reported outcome measure; PROM; supportive care;
Keywords: مولتیپل میلوما; Bisphosphonates; Maintenance therapy; Multiple myeloma; Skeletal events; Zoledronic acid;
Keywords: مولتیپل میلوما; Autologous stem cell transplantation; Carfilzomib; Daratumumab; Ixazomib; Multiple myeloma;
Keywords: مولتیپل میلوما; Multiple myeloma; Autologous stem cell transplantation; Survival;
Keywords: مولتیپل میلوما; Nutritional assessment; Patient-Generated Subjective Global Assessment; Multiple myeloma; Prognosis;
Keywords: مولتیپل میلوما; AI; aromatase inhibitor; BMD; bone mineral density; BMI; body mass index; Bone; Breast cancer; Chemotherapy; Multiple myeloma; Prostate cancer; Denosumab; Zoledronic acid;
Keywords: مولتیپل میلوما; Palliative care; palliative medicine; hematology; multiple myeloma; pain; neoplasms;
Keywords: مولتیپل میلوما; Myeloid sarcoma; Acute myeloid leukemia; Plasmacytoma; Multiple myeloma; Lymphoblastic lymphoma; Lymphoblastic leukemia;
Keywords: مولتیپل میلوما; Autologous transplantation; Cost saving; DRG; Multiple myeloma; Outpatient;
Keywords: مولتیپل میلوما; Allogeneic hematopoietic transplantation; Post-transplantation cyclophosphamide; Multiple myeloma;
Keywords: مولتیپل میلوما; Plasmin; Multiple myeloma; Microenvironment; Fibrinolysis;
Keywords: مولتیپل میلوما; CVA; cerebrovascular accident; CT; computerized tomography angiography; DVT; deep venous thrombosis; ETP; endogenous thrombin potential; IMiD; immunomodulatory drugs; MM; multiple myeloma; TF; tissue factor; TG; thrombin generation; PE; pulmonary embolism
Keywords: مولتیپل میلوما; C-X-C chemokine receptors; Microenvironment; Positron emission tomography; Theranostics; Acute myeloid leukemia; Lymphoma; Multiple myeloma;
Keywords: مولتیپل میلوما; CLK; CDC-like kinase; hnRNP; heterogeneous nuclear ribonucleoprotein; HIF; hypoxia induced factor; KLF6; Krüppel-like factor 6; MM; multiple myeloma; NEK2; NIMA-related kinase 2; PHLPP1; pleckstrin homology (PH) domain leucine-rich repeat protein phospha
Keywords: مولتیپل میلوما; Actionable mutation; Driver; Immunotherapy; Multiple myeloma; Target therapy;
Keywords: مولتیپل میلوما; Plasma cell dyscrasia; Plasma cell neoplasm; Multiparametric flow cytometry; Multiple myeloma; Minimal residual disease; MRD; Panel optimization; High-sensitivity assay;
Keywords: مولتیپل میلوما; AML; acute myeloid leukemia; BRCA; breast cancer; BRCC3; BRCA1/BRCA2-Containing Complex Subunit 3; C; constant; CLL; chronic lymphocytic leukemia; CML; chronic myeloid leukemia; CSC; cancer stem-like cell; EGFR; epidermal growth factor receptor; EMT; epit
Keywords: مولتیپل میلوما; Multiple myeloma; Immunotherapy; Monoclonal antibodies; Chimeric antigen receptor (CAR) T cells; Checkpoint inhibitors; Allogeneic stem cell transplantation;
Keywords: مولتیپل میلوما; Wnt/βcatenin signaling; Bone formation; Bone resorption; Osteocytes; Anabolism; PTH; Glucocorticoids; Multiple myeloma;
Keywords: مولتیپل میلوما; AIF; apoptosis inducing factor; Ang; angiopoietin; AP-1; activator protein-1; APEX; Assessment of Proteasome Inhibition for Extending Remissions; ATP; adenosine-5â²-triphosphate; BiPN; bortezomib-induced peripheral neuropathy; CiPN; chemotherapy-induced
Keywords: مولتیپل میلوما; szpiczak plazmocytowy; rozpoznanie; nowe leki; rozważania lecznicze; Multiple myeloma; Diagnosis; New drugs; Therapeutic considerations;
Keywords: مولتیپل میلوما; ADA; anti-drug antibody; ALN; alendronate; AUC; area under curve; BFR/BS; bone formation rate per bone surface; BMD; bone mineral density; bSEM; backscattered scanning electron microscopy; CKD-MBD; chronic kidney disease-mineral and bone disorder; CTX; ca
Keywords: مولتیپل میلوما; Smoldering multiple myeloma; Plasma cell; Multiple myeloma;
Keywords: مولتیپل میلوما; total joint arthroplasty; multiple myeloma; outcome; perioperative; mortality;
Keywords: مولتیپل میلوما; Multiple myeloma; Spine myeloma; Spinal surgery; Radiotherapy; Chemotherapy; Neurological involvement;
Keywords: مولتیپل میلوما; Allograft; light chain proximal tubulopathy (LCPT); recurrent LCPT; monoclonal gammopathy; monoclonal gammopathy of undetermined significance (MGUS); multiple myeloma; kidney biopsy; renal transplantation;
Keywords: مولتیپل میلوما; Free light chains; Multiple myeloma; Myelomatous pleural effusion;
Keywords: مولتیپل میلوما; angiogenesis; cytokines; mast cells; multiple myeloma;
Keywords: مولتیپل میلوما; Multiple myeloma; Computed tomography; Target lesions; Medullary involvement; Therapy response;
Keywords: مولتیپل میلوما; Centrosome amplification; Proliferation; Clonal diversification; Multiple myeloma;
Keywords: مولتیپل میلوما; multiple myeloma; urokinase-type plasminogen activator receptor; bone marrow; urokinase;
Keywords: مولتیپل میلوما; Future fracture-free survival; Kaplan-Meier analysis; Height loss; Multiple myeloma; Multivariable regression; Vertebral fracture;
Keywords: مولتیپل میلوما; temporomandibular joint; TMJ; temporomandibular disorder; multiple myeloma;
Keywords: مولتیپل میلوما; Multiple myeloma; Allogeneic; Myeloablative; Reduced toxicity; Prospective; Fludarabine; Busulfan
Keywords: مولتیپل میلوما; Body mass index; Glycated hemoglobin; Multiple myeloma; Peripheral neuropathy; Predictors
Keywords: مولتیپل میلوما; Freelite®; Serum free light chain assay; Total light chain assay; Multiple myeloma
Keywords: مولتیپل میلوما; Multiple myeloma; Paracrine cytokines; Joint myeloma/osteoclast cells; Mathematical modelling;
Keywords: مولتیپل میلوما; Multiple myeloma; Galactomannan; False positive; Cancer; Adult;
Keywords: مولتیپل میلوما; Multiple myeloma; Elderly; Autologous stem cell transplantation; Population-based survival analysis;
Keywords: مولتیپل میلوما; Multiple myeloma; Smoldering myeloma; MGUS; Epidemiology; Health disparity;
Keywords: مولتیپل میلوما; Immune system; Influenza; Multiple myeloma; Pneumonia; Supportive care;
Keywords: مولتیپل میلوما; Bone marrow transplantation; Multiple myeloma; Granulocyte-colony stimulating factor; Cyclophosphamide;
Keywords: مولتیپل میلوما; ALP; alkaline phosphatase; Cbfa1; core-binding factor subunit alpha-1; DKK; dickkopf; MM; multiple myeloma; MP; melphalan with prednisone; OPG; osteoprotegerin; PTH; parathyroid hormone; PTHrP; parathyroid hormone-related protein; PTHR1; parathyroid hormo